Anika Therapeutics, Inc.ANIKNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P21
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -11.64% |
| 2024 | -7.29% |
| 2023 | 16.97% |
| 2022 | -30.86% |
| 2021 | 23.36% |
| 2020 | 71.85% |
| 2019 | 1.79% |
| 2018 | 59.41% |
| 2017 | 19.58% |
| 2016 | 21.50% |